Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial. Guckenberger M, Opitz I, Dellaporta T, Curioni-Fontecedro A, et al. Lung Cancer 2025;204:108553.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guckenberger M, Opitz I, Dellaporta T, Curioni-Fontecedro A, et al. Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial. Lung Cancer 2025;204:108553.
PMID: 40311307